Pfizer Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (378)

Latest Posts

About This Stock More About This Stock
Healthcare ETF (VHT) Hits New 52-Week High
Article By: Zacks Investment Research
Friday, October 20, 2017 8:03 PM EDT
Investors seeking momentum may have Vanguard Healthcare ETF on their radar now. The fund recently hit a new 52-week high. Shares of VHT are up approximately 29.2% from the 52-week low of $120.38/share.
In this article: JNJ, PFE, UNH, VHT
Read
Why Are These 6 Dow Stocks Fairly Valued? - Part 4
Video By: Chuck Carnevale
Thursday, October 19, 2017 10:04 AM EDT
I will present a quick overview of six Dow constituents based primarily on price relative to earnings and cash flow.
In this video: AXP, GE, MRK, PFE, TRV, JPM
Watch
5 Pharma & Biotech Stocks That Could Be Big Winners In Q3 Earnings
Article By: Arpita Dutt
Tuesday, October 10, 2017 4:34 PM EDT
Pharma and biotech stocks started 2017 on a strong note with this part of the market remaining in favor as the year progresses. So far this year, the Nasdaq Biotechnology Index is up 25.6%.
In this article: LLY, MRK, PFE, BIIB, VRTX Also: NVS, GILD
Read
Forget Teva, Buy These 5 Drug Stocks Instead
Article By: Arpita Dutt
Monday, October 9, 2017 1:43 PM EDT
While Teva deals with these challenges, I have selected five drug companies that look well-positioned.
In this article: PFE, LGND, AMGN, CELG, VRTX Also: MYL, TEVA
Read
Pfizer Takes J&J To Court As Analysts Shake Up Pharma Ratings
Article By: The Fly
Wednesday, September 20, 2017 11:05 AM EDT
Morgan Stanley analyst David Risinger upgraded Pfizer this morning to Overweight, a Buy-equivalent rating, as he believes investors underappreciate the global prospects for breast cancer drug Ibrance.
In this article: PFE Also: JNJ, NVS, LLY, ABBV, BMY
Read

PARTNER HEADLINES

Latest Tweets for $PFE

No tweets yet!